The Battle for the Cath Lab Cockpit: Why Philips’ Acquisition of SpectraWAVE Resets the Interventional Stack
Date: December 23, 2025 | Topic: Medical Imaging & Interventional Strategy | Company: Royal Philips (NYSE: PHG) Philips’ acquisition of SpectraWAVE is not a product expansion—it is a platform defense designed to close the company’s only major strategic gap against Abbott and Boston Scientific: the integrated high-resolution imaging stack. Executive Brief: The “So What” Philips’ […]
